Fundraising Fox

Michael A. Metzger

Chief Executive Officer at Syndax Pharmaceuticals

New York, New York, United States

Find your path to Michael

Chief Executive Officer at Syndax Pharmaceuticals

Intro paths

→

In turn, Michael can intro founders to Syndax Pharmaceuticals's investors below.

Syndax Pharmaceuticals's investors · 7

BlackRockWilmingtonDomain AssociatesPrinceton · $200K – $15M checksForesite CapitalWest HollywoodMPM BioImpactBoston · $1M – $15M checksPappas CapitalDurhamSofinnova VenturesMenlo Park · $100K – $15M checksvenBio PartnersSan Francisco

Experience

  1. Pyxis OncologyMember Board of Directorscurrent2024 — presentBoston, Massachusetts, United States
  2. Syndax PharmaceuticalsChief Executive Officer and Directorcurrent2022 — presentWaltham, Massachusetts
  3. Syndax PharmaceuticalsPresident, Chief Operating Officer and Director2015 — 2022Waltham, Massachusetts
  4. CTI BioPharmaMember Board of Directors2017 — 2023Seattle, Washington
  5. Tarveda TherapeuticsMember Board of Directors2017 — 2022Watertown, Massachusetts
  6. Regado BioSciences, Inc.President and Chief Executive Officer2014 — 2015Basking Ridge, New Jersey
  7. Regado BioSciences, Inc.President and Chief Operating Officer2013 — 2015Basking Ridge, New Jersey
  8. Mersana TherapeuticsExecutive Vice President and Chief Operating Officer2011 — 2013Cambridge, Massachusetts
  9. Response GeneticsMember Board of Directors2010 — 2013Los Angeles, California
  10. Forest LaboratoriesSenior Director Business Development2006 — 2011New York, New York
  11. Onconova Therapeutics Inc.VP Corporate Development2001 — 2006Lawrenceville, New Jersey
  12. MESA PartnersManaging Director1997 — 2001
  13. Oxford Health PlansManager1995 — 1997New York, New York

Skills & more

Company Management1Capital Formation and DeploymentCorporate StrategyBusiness Development15Mergers5Biotechnology22Venture Capital17Start-ups16

From Michael's professional profile.

Frequently asked questions

Who is Michael A. Metzger?
Chief Executive Officer at Syndax Pharmaceuticals
Where does Michael A. Metzger work?
Michael A. Metzger is Chief Executive Officer at Syndax Pharmaceuticals.
Where did Michael A. Metzger go to school?
Michael A. Metzger studied at NYU Stern School of Business (MBA, Finance); The George Washington University (B.A., Political Science).

Same school

Also attended NYU Stern School of Business736

Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsMax WechterSenior Director of AI at Lerer HippeauKrupa VankayalaPartner, People & HR at Sapphire VenturesDanny BrowneInvestor at FJ Labs

+ 730 more

Also attended The George Washington University330

RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauZach CollinsPartner at Mission Biocapital

+ 324 more

Shared employers

Also worked at CTI BioPharma4

Laurent FischerDirector at atai Life SciencesJohn VolponeExecutive Officer at X4 PharmaceuticalsJames BiancoExecutive Officer, Director at TuHURA Biosciences Inc./NVDavid KirskeExecutive Officer at X4 Pharma

Also worked at Regado BioSciences, Inc.1

David J. MazzoExecutive Officer, Director at Caladrius Biosciences

Also worked at Mersana Therapeutics1

Donald A. BergstromExecutive Officer at Relay Therapeutics

Also worked at Forest Laboratories12

Jayson RiegerManaging Partner at PBM CapitalJeffrey M. JonasPartner at Cure VenturesJulia StephanusPartner at Borealis VenturesIvan GergelManaging Partner and Chief Medical Officer at New Rhein Healthcare Investors, LLCStephen LePartner at MBK PartnersKristen RooneyHead of Business Development at Third Prime

+ 6 more